Dr. Renee Diane Wegrzyn (born 1976)
Mentioned in Influenza season of 2019 to 2020 (United States) ...
https://en.wikipedia.org/wiki/Renee_Wegrzyn
2022-10-12-wikipedia-org-renee-wegrzyn.pdf
Renee Wegrzyn
From Wikipedia, the free encyclopedia
Renee Wegrzyn
Director of the Advanced Research Projects Agency for Health
Nominee
Assumed office
TBD
Appointed by
Deputy
Adam H. Russell (acting)
Preceded by
Position established
Personal details
Born
1976/1977 (age 45–46)
Education
Georgia Institute of Technology (BS, MS, PhD)
Renee Wegrzyn (born 1976/1977)[1] is an American applied biologist who was selected to serve as director of the newly-created Advanced Research Projects Agency for Health.
Wegrzyn earned a Bachelor of Science and PhD in applied biology from Georgia Tech.[2][3]
From 2003 to 2006, Wegrzyn worked as a post-doctoral research fellow at the European Molecular Biology Laboratory. From 2006 to 2008, she worked as the assay development group leader for Adlyfe, a biotechnology company based in Quebec. In 2009, she was a senior scientist at Meso Scale Discovery and in 2012, she was a fellow at the Johns Hopkins Center for Health Security. From 2009 to 2016, she worked as a senior lead technologist at Booz Allen Hamilton. From 2016 to 2020, she served as a program manager in the Biological Technologies Office of DARPA, where she specialized in synthetic biology and biosecurity. Since 2018, she has been a senior advisor to the Nuclear Threat Initiative.[4] In 2020, she joined Ginkgo Bioworks as vice president of business development.[5]
^ Kaiser, Jocelyn (September 12, 2022). "Biden's New Biomedical Innovation Agency Gets Its First Director". Science. Retrieved September 22, 2022.
^ "President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H)". The White House. 2022-09-12. Retrieved 2022-09-12.
^ "DARPA Forward | Dr. Renee Wegrzyn". forward.darpa.mil. Retrieved 2022-09-12.
^ "Biden appoints former government scientist as first leader of ARPA-H". STAT. 2022-09-12. Retrieved 2022-09-12.
^ Stolberg, Sheryl Gay (2022-09-12). "Biden Picks Biotech Executive to Lead New Biomedical Research Agency". The New York Times. ISSN 0362-4331. Retrieved 2022-09-12.
2022-09-12-whitehouse-gov-press-president-biden-announces-intent-to-appoint-dr-renee-wegrzyn-as-inaugural-director.pdf
2022-09-12-whitehouse-gov-press-president-biden-announces-intent-to-appoint-dr-renee-wegrzyn-as-inaugural-director-img-1.jpg
SEPTEMBER 12, 2022
President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H)
HOME
BRIEFING ROOM
STATEMENTS AND RELEASES
Today, President Joe Biden announced his intent to appoint Dr. Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health (ARPA-H), a new agency established to drive biomedical innovation that supports the health of all Americans. On the 60th anniversary of President John F. Kennedy’s Moonshot speech, Dr. Wegrzyn will join President Biden today at the John F. Kennedy Presidential Library in Boston as he discusses his bold vision for another American Moonshot: ending cancer as we know it.
Dr. Wegrzyn, a scientist with professional experience working for two of the institutions that inspired the creation of ARPA-H – the Defense Advanced Research Projects Agency (DARPA) and Intelligence Advanced Research Projects Activity (IARPA) – will be responsible for driving the agency’s nascent research portfolio and associated budget. The budget is expected to support a broad range of programs in order to develop capabilities to prevent, detect and treat some of the most intractable diseases including cancer.
President Biden created ARPA-H in March 2022 to push the limits of U.S. biomedical and health research and innovation. ARPA-H will embrace proven models of tapping talent and expertise from across industry, academia, and government to bring new ideas and approaches, as well as the ability to marshal resources through public-private partnerships. Equity will be important to ARPA-H’s mission, which will ensure all projects consider equity in their design, support impactful breakthroughs, expand health care access, and improve access for all patients regardless of race, ethnicity, gender, gender identity, sexual orientation, disability, and income level.
Dr. Renee Wegrzyn, Inaugural Director, Advanced Research Projects Agency for Health (ARPA-H)
Dr. Renee Wegrzyn is currently a vice president of business development at Ginkgo Bioworks and Head of Innovation at Concentric by Ginkgo, where she is focused on applying synthetic biology to outpace infectious diseases – including COVID-19 – through biomanufacturing, vaccine innovation, and biosurveillance of pathogens at scale.
Prior to Ginkgo Bioworks, Wegrzyn was program manager in the Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA), where she leveraged the tools of synthetic biology and gene editing to enhance biosecurity, promote public health, and support the domestic bioeconomy. Her DARPA portfolio included the Living Foundries: 1000 Molecules, Safe Genes, Preemptive Expression of Protective Alleles and Response Elements (PREPARE), and Detect it with Gene Editing Technologies (DIGET) programs.
Wegrzyn received the Superior Public Service Medal for her work and contributions at DARPA. Prior to joining DARPA as a program manager, Wegrzyn led technical teams in private industry in the areas of biosecurity, gene therapies, emerging infectious disease, neuromodulation, synthetic biology, as well as research and development teams commercializing multiplex immunoassays and peptide-based disease diagnostics.
Wegrzyn served on the scientific advisory boards for the National Academies of Science Board on Army Research and Development, Revive & Restore, Air Force Research Labs, Nuclear Threat Initiative, and the Innovative Genomics Institute. She holds doctorate and bachelor’s degrees in applied biology from the Georgia Institute of Technology, was a fellow in the Center for Health Security Emerging Leaders in Biosecurity Initiative (ELBI), and completed her postdoctoral training as an Alexander von Humboldt Fellow in Heidelberg, Germany.
Renee Diane Wegrzyn
Add or update information
Detail Source
Name:
Renee Diane Wegrzyn
Birth Date:
Nov 1976
Residence Date:
2011-2020
Address:
5117 Wissioming Rd
Residence:
Bethesda, Maryland, USA
Postal Code:
20816
Second Residence Date:
2007-2020
Second Address:
1221 Duncan Pl Ne
Second Residence:
Washington, District of Columbia, USA
Second Postal Code:
20002
Third Residence Date:
1999-2009
Third Address:
119 Center St NW
Third Residence:
Atlanta, Georgia, USA
Third Postal Code:
30313
Fourth Residence Date:
2000-2008
Fourth Address:
2356 Sarazen Dr
Fourth Residence:
Dunedin, Florida, USA
Fourth Postal Code:
34698
2022-10-12-ancestry-com-directory-info-renee-wegrzyn.pdf
Renee D Wegrzyn
Add or update information
Detail Source
Name:
Renee D Wegrzyn
Birth Date:
25 Nov 1976
Address:
1 Fliederweg
Residence Place:
Dossenheim D692
Zip Code:
69221
2019 (Dec 23) - The Sacramento Bee : "Lethal flu strains, dirty radiation bombs - can humans survive? "
Mentioned : Dr. Renee Diane Wegrzyn (born 1976) / Influenza season of 2019 to 2020 (United States)